# Amphora Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amphora-medical

- Industry: Medical Devices & Equipment
- Headquarters: Maple Grove, US
- Website: www.amphoramedical.com
- Total disclosed funding: $42M
- Latest round: Series B (Jul 20, 2017)
- Investors on record: 5

## About

Amphora Medical, Inc. specializes in developing innovative healthcare solutions aimed at improving operational efficiency and data management for healthcare providers and other sectors.Founded in 2011 by Danny Sachs in Maple Grove, US, Amphora Medical, Inc. focuses on healthcare technology. The company raised USD 35.5 mn in its most recent funding round, Series B, on July 20, 2017, with participation from Baird Capital Partners, Boston Scientific, F-Prime Capital, HBM Partners, and Longitude Capital. Amphora Medical has successfully completed 3 deals to date.The company's core product offerings focus on innovative solutions designed to streamline operations and enhance productivity across multiple sectors. Their flagship product is a robust software platform that integrates seamlessly with existing systems, facilitating real-time data analysis and reporting. This platform primarily targets industries such as healthcare, finance, and manufacturing, aiming to resolve challenges related to data management and operational efficiency. The products have been tailored for a diverse clientele, including regional banks, healthcare providers, and large manufacturing firms, serving both B2B and direct-to-consumer markets. The company's solutions are marketed primarily in North America and Europe, addressing the specific regulatory and operational needs of these geographies since their initial release in the last three years.The company's revenue model is structured around a subscription-based approach, allowing clients to access the software platform through tiered pricing plans that cater to different organizational sizes and needs. This structure includes options for annual subscriptions as well as month-to-month agreements, ensuring flexibility for clients. Transactions typically occur directly between the firm and its clients, with additional avenues for partnerships that enhance value delivery. The revenue from these subscriptions is bolstered by ancillary services, including training and technical support, which are often bundled with the primary product offerings. Although specific pricing details are proprietary, the tiered structure allows for scalable access to the company's trademarked solutions, facilitating growth in client investment as their operational needs evolve.Amphora Medical plans to leverage the USD 35.5 mn raised in their Series B funding to support the development of new healthcare solutions and expand into new geographic markets. The company is focusing on introducing additional software features and products aimed at enhancing patient care and operational efficiency by 2018. Furthermore, Amphora Medical aims to penetrate the European markets more aggressively and increase its client base by establishing partnerships with European healthcare institutions by 2019.

## Funding rounds

- Series B, Jul 20, 2017, $36M — Baird Capital Partners, HBM Partners, Boston Scientific, F-Prime Capital, Longitude Capital
- Series A, May 24, 2013, $6M — Baird Capital Partners

## Investors

- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series A, Series B
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B
- Boston Scientific — Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B
- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series B